Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Sold by Hudson Edge Investment Partners Inc.

Hudson Edge Investment Partners Inc. trimmed its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 61.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,177 shares of the real estate investment trust’s stock after selling 16,146 shares during the quarter. Hudson Edge Investment Partners Inc.’s holdings in Sabra Health Care REIT were worth $176,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Geode Capital Management LLC raised its stake in Sabra Health Care REIT by 1.7% in the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after purchasing an additional 104,533 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Sabra Health Care REIT by 222.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after purchasing an additional 6,819,919 shares during the last quarter. Vestcor Inc raised its stake in Sabra Health Care REIT by 62.5% in the 3rd quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock valued at $3,869,000 after purchasing an additional 79,956 shares during the last quarter. Barclays PLC raised its stake in Sabra Health Care REIT by 56.1% in the 3rd quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock valued at $12,624,000 after purchasing an additional 243,895 shares during the last quarter. Finally, Franklin Resources Inc. raised its stake in Sabra Health Care REIT by 12.3% in the 3rd quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock valued at $9,543,000 after purchasing an additional 57,551 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Health Care REIT Price Performance

SBRA opened at $15.89 on Friday. The stock’s 50-day moving average price is $16.85 and its 200 day moving average price is $17.62. Sabra Health Care REIT, Inc. has a 12-month low of $13.31 and a 12-month high of $20.03. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The firm has a market cap of $3.78 billion, a price-to-earnings ratio of 29.98, a PEG ratio of 1.97 and a beta of 1.25.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. As a group, sell-side analysts expect that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 7.55%. The ex-dividend date of this dividend is Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio is currently 226.42%.

Analysts Set New Price Targets

Several research analysts recently commented on the company. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research note on Tuesday, January 7th. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and lowered their price target for the stock from $18.00 to $17.00 in a report on Friday, January 17th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Finally, Mizuho reiterated a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Three equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $18.86.

Sabra Health Care REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.